Leila Hawkins
More content by Leila Hawkins
“Diversity brings better science to the table”
December 16 by Leila Hawkins
Yusuf Henriques, founder of IndyGeneUS AI, tells Pharma IQ about the need to rethink precision medicine
The pharma company with a build-as-you go approach
November 30 by Leila Hawkins
Pharma IQ speaks to Amarin’s SVP for Europe about the company’s unique market strategy
Highlights from Future Lab Informatics 2022
November 22 by Leila Hawkins
Speakers from AstraZeneca, Merck, Moderna and Johnson & Johnson on building the lab of the future
Respiratory syncytial virus and the race for a vaccine
November 21 by Leila Hawkins
As cases of RSV surge vaccine manufacturers are racing to find a treatment
Five antiviral Covid treatments are too expensive, says UK government body
November 16 by Leila Hawkins
UK agency deems treatments too costly, prompting backlash
How big pharma is focusing on diversity, equity and inclusion
November 11 by Leila Hawkins
As Bayer tops list for DEI efforts, we look at how this impacts clinical research
Why digital transformation is essential to get value from R&D data
November 09 by Leila Hawkins
Pharma IQ looks at the benefits of moving to a digital lab
Meet Pharma IQ’s advisory board: Nathalie Maubon
November 08 by Leila Hawkins
Pharma IQ’s advisory board member Nathalie Maubon on the future of drug testing
Big pharma CEOs announce net zero action plan
November 03 by Leila Hawkins
Seven major pharma companies join forces to tackle the sector’s greenhouse gas emissions
Bivalent Covid-19 vaccines: What they are and what they do
November 01 by Leila Hawkins
As bivalent Covid-19 vaccines are rolled out, we look at how effective they are
“An exciting time for pharma”– Pharma IQ’s panel on the future of drug discovery
October 28 by Leila Hawkins
Leading experts came together to discuss the future of pharma in Pharma IQ’s recent webinar
Uganda declares lockdown, Merck to donate vaccine to tackle Ebola
October 26 by Leila Hawkins
Uganda is trying to contain the latest outbreak of the Sudan variant of Ebola
